Carlson Caspers represented Glenmark in this Hatch-Waxman patent litigation concerning Glenmark’s Paragraph IV ANDA challenge of 3 patents covering the formulation and uses of dronedarone (Multaq®).  We achieved a successful settlement for our client on the eve of trial.